Purchase Order HHSN269201700549P
Award Date 7/24/17
Potential Completion Date 9/22/23
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Fenwal, Inc., a subsidiary of Fresenius Kabi and global blood technology company headquartered in Lake Zurich, Illinois, has been awarded a firm fixed-price purchase order from the National Institutes of Health Clinical Center valued at $18,920.00. The contract, awarded on December 14, 2025, with an ultimate completion date of December 13, 2026, carries no set-aside designation. As a critical supplier of specialized blood collection, separation, storage, and transfusion products and equipment,...
- The National Institutes of Health Clinical Center awarded a purchase order to Fenwal, Inc. valued at $46,200.00 on July 1, 2017, for blood collection, separation, storage, and transfusion products and related medical consumables. Place of performance is Bethesda, Maryland. The order carries firm fixed-price pricing with no set-aside designation. Ultimate completion was scheduled for June 30, 2018. Fenwal is a blood technology manufacturer specializing in collection assemblies, anticoagulant...
- This federal contract award, valued at $1,062.50, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi. The contract is for the supply of various blood collection and processing products, including blood bags, tubing, solutions, and apheresis equipment, to support transfusion medicine and cell therapy applications for federal agencies such as the Department of Defense, Department of Veterans Affairs, and National Institutes of Health....
- This purchase order, valued at $13,000, was awarded to Fenwal, Inc. on March 25, 2010, for service contract support of AMICUS-B1 apheresis machines (Serial #D0904M4055 and D0904M4062) at the National Institutes of Health Clinical Center in Bethesda, Maryland. The contract, which was funded through the Office of the Chief Operating Officer and had an ultimate completion date of May 4, 2011, was awarded without set-aside designation, reflecting Fenwal's specialized capabilities in apheresis...
- The NIH Clinical Center awarded a purchase order to Fenwal, Inc. valued at $13,000 on June 20, 2017, for blood technology products and services. Performance was to occur in Bethesda, Maryland, with an ultimate completion date of July 31, 2018. The order was issued on a firm fixed-price basis without set-aside designation. Fenwal, a specialist in blood collection, separation, storage, and transfusion products, supplied blood banking consumables and equipment to support the Clinical Center's...
- <p>The NIH Clinical Center awarded a purchase order to Fenwal, Inc. for $24,967.20 on September 20, 2018, with completion by January 2, 2019. The order procures AMICUS apheresis kits. Performance takes place in Lake Zurich, Illinois. Fenwal is a blood technology manufacturer specializing in collection, separation, storage, and transfusion products and equipment. The contract carries firm fixed-price pricing with no set-aside designation.</p>
- This is a $21,400 firm-fixed-price purchase order awarded to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, by the Defense Health Agency. The contract is for the supply of various medical supplies and equipment to support transfusion medicine and cell therapy applications, including blood bags, tubing, solutions, apheresis equipment, and other specialized items used in blood banking and biomedical research operations. The award does not have a set-aside...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $10,813 purchase order to Fenwal, Inc. of Long Grove, Illinois for AMICUS apheresis single and double needle kits. The firm fixed price order is for products to be delivered between November 14 and December 14, 2023 in support of blood collection and separation activities at the Clinical Center. Fenwal will provide the requested medical supply items as the prime contractor. No subcontractors or...
- This federal contract award to Fenwal, Inc., a subsidiary of Fresenius Kabi, is for a Preventative Maintenance Agreement for two ALYX apheresis machines at the National Institutes of Health (NIH) Clinical Center in Bethesda, Maryland. The contract has a ceiling value of $11,170.00 and is a firm fixed-price purchase order with an ultimate completion date of October 31, 2025. The contract was awarded on October 31, 2024, and does not have a set-aside designation. Fenwal, Inc. is a global blood...
- This federal contract award is for the procurement of AMICUS cell separators and accessories by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government. The $110,982.87 firm fixed-price purchase order was awarded to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract has a period of performance ending on September 3, 2025. Fenwal, which is a registered vendor with the U.S. federal government, has a...